Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Bei Gene, Ltd. Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$92.2 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	BUY	$131.8 - $202.24 $395,400 - $606,720	3,000 Added 18.67%	19,071 $2.57 Million
Q1 2022 May 09, 2022	BUY	$146.52 - $269.56 $246,300 - $453,130	1,681 Added 11.68%	16,071 $3.03 Million
Q4 2021 Feb 07, 2022	BUY	$248.56 - $389.34 $428,268 - $670,832	1,723 Added 13.6%	14,390 $3.88 Million
Q3 2021 Nov 04, 2021	BUY	$249.6 - $403.14 $189,945 - $306,789	761 Added 6.39%	12,667 $4.6 Million
Q2 2021 Aug 06, 2021	BUY	$292.75 - $367.01 $345,152 - $432,704	1,179 Added 10.99%	11,906 $4.09 Million
Q1 2021 May 06, 2021	BUY	$260.64 - $382.12 $292,177 - $428,356	1,121 Added 11.67%	10,727 $3.73 Million
Q4 2020 Feb 09, 2021	BUY	$221.31 - $316.61 $483,783 - $692,109	2,186 Added 29.46%	9,606 $2.48 Million
Q3 2020 Nov 10, 2020	BUY	$189.18 - $286.44 $240,636 - $364,351	1,272 Added 20.69%	7,420 $2.13 Million
Q2 2020 Aug 06, 2020	BUY	$123.9 - $195.41 $82,393 - $129,947	665 Added 12.13%	6,148 $1.16 Million
Q1 2020 May 11, 2020	SELL	$121.84 - $173.19 $2,193 - $3,117	-18 Reduced 0.33%	5,483 $675,000
Q4 2019 Feb 05, 2020	BUY	$115.78 - $208.34 $76,762 - $138,129	663 Added 13.7%	5,501 $893,000
Q2 2019 Aug 08, 2019	BUY	$113.99 - $146.86 $123,109 - $158,608	1,080 Added 28.74%	4,838 $600,000
Q4 2018 Feb 08, 2019	BUY	$107.01 - $175.15 $402,143 - $658,213	3,758 New	3,758 $482,000

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$2.03 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.24 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$995 Million
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$956 Million
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$712 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.9B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account